KR » Topics » E QUITY C OMPENSATION P LAN I NFORMATION

This excerpt taken from the KR DEF 14A filed May 15, 2007.

EQUITY COMPENSATION PLAN INFORMATION

     The following table provides information regarding shares outstanding and available for issuance under the Company’s existing equity compensation plans.

  (a)  (b) (c)
  Plan Category    Number of securities    Weighted-average    Number of securities 
    to be issued upon    exercise price of    remaining for future 
    exercise of    outstanding options,    issuance under equity 
    outstanding options,    warrants and rights    compensation plans 
    warrants and rights        excluding securities 
          reflected in column (a) 
  Equity compensation plans approved by         
       security holders  51,918,179   $ 20.09   17,595,505  
  Equity compensation plans not approved by         
       security holders    $    
  Total  51,918,179   $ 20.09   17,595,505  

This excerpt taken from the KR DEF 14A filed May 16, 2005.

EQUITY COMPENSATION PLAN INFORMATION

 

The following table provides information regarding shares outstanding and available for issuance under the Company’s existing stock option plans.

 

    (a)     (b)   (c)
Plan Category   Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
    Weighted-average
exercise price of
outstanding options,
warrants and rights
  Number of securities
remaining for future
issuance under equity
compensation plans
(excluding securities
reflected in column (a)

Equity compensation plans approved by security holders

  65,649,738 (1)   $ 17.8049   8,072,418

Equity compensation plans not approved by security holders

  1,200     $ 6.4850  

Total

  65,650,938 (1)   $ 17.8047   8,072,418

 

The securities to be issued under stock plans not approved by shareholders related to options issued under the Company’s 1987 Stock Option plan and 1988 Stock Option Plan. These plans provided for the issuance of nonqualified stock options and restricted stock to employees of the Company. Both plans expired 10 years after adoption. Although outstanding options continue to be exercisable in accordance with their terms, no additional options may be issued from these plans.

 

(1)   This amount includes 4,163,863 warrants outstanding and originally issued to The Yucaipa Companies pursuant to a Warrant Agreement dated as of May 23, 1996, between Smith’s Food & Drug Centers, Inc. and The Yucaipa Companies, as Consultant.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki